Visionary Move: Lupin Buys VISUfarma for €190 Million, Boosting Eye Care Portfolio

Lupin Limited has announced a significant strategic acquisition through its wholly owned subsidiary, Nanomi B.V., signing a definitive agreement to acquire 100% share capital of VISUfarma B.V. for an enterprise value of €190 million. This deal marks a decisive step by Lupin to expand its specialty ophthalmology business and enhance its presence in the fast-growing European market.

Key Highlights From The Acquisition Deal

Lupin to acquire entire shareholding of VISUfarma B.V., a European specialty pharmaceutical company focused on ophthalmology

Enterprise value of the deal set at €190 million, financed through Lupin’s existing cash reserves

VISUfarma’s portfolio includes over 60 branded products addressing dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health, and nutraceuticals

The acquisition advances Lupin’s goal to broaden its specialty franchise and European footprint

Strategic Rationale Behind The Deal

By integrating VISUfarma’s established commercial infrastructure and strong pan-European presence across countries such as Italy, UK, Spain, Germany, and France, Lupin aims to accelerate growth in specialty ophthalmology. The expanding market is driven by a rising aging population, increasing diabetes-related eye diseases, and greater focus on preventive eye care. Lupin expects the acquisition to be immediately accretive, strengthening its growth and margin profile while supporting global portfolio expansion.

Industry Impact And Future Prospects

The move positions Lupin as a growing leader in specialty pharmaceuticals for eye health, combining research-led innovation and commercial scale. VISUfarma’s robust pipeline and market reach fit well within Lupin’s long-term strategy to capitalize on increasing demand for advanced ophthalmic therapies globally. The transaction is expected to close by end of 2025, subject to regulatory approvals.

Sources: Lupin Official Release, Business Standard, Economic Times, Market Screener